Literature DB >> 32037945

Clinical Correlates of Smoking Status in Men and Women with Opioid Use Disorder.

R Kathryn McHugh1,2, Amy C Janes2,3, Margaret L Griffin1,2, Nadine Taghian1, Shelly F Greenfield1,2, Roger D Weiss1,2.   

Abstract

Background: Smoking is highly prevalent in people with opioid use disorder (OUD) and is a significant contributor to morbidity and mortality in this population. However, little is known about the differences between those with OUD who do and do not smoke cigarettes.
Objectives: Our aim was to investigate differences between treatment-seeking adults with OUD who did and did not smoke.
Methods: Participants (N = 568; 30% female) completed a battery of self-report questionnaires including measures of current smoking status and number of cigarettes smoked per day as well as measures of clinical characteristics (e.g. craving, anxiety).
Results: Of the total sample, 77% were current smokers. Multivariable logistic regression identified heroin use (OR = 2.20, 95% CI = 1.38, 3.53) and younger age (OR = 0.97, 95% CI = 0.95, 0.997) as strong correlates of smoking status; other characteristics were not significant. Older age and opioid craving were associated with more cigarettes smoked per day. Notably, these patterns differed for males and females; opioid craving (B = 0.62, SEB = 0.24) was associated with the number of cigarettes smoked among men, and anxiety (B = 0.39, SEB = 0.19) was associated with the number of cigarettes smoked among women.
Conclusion: Adults with OUD who used heroin in the past month were more likely to be current smokers. No sex differences were observed in likelihood of smoking; however, the predictors of smoking status and severity differed between men and women.

Entities:  

Keywords:  Opioid use disorder; anxiety; sex differences; smoking

Mesh:

Year:  2020        PMID: 32037945      PMCID: PMC7180131          DOI: 10.1080/10826084.2020.1725056

Source DB:  PubMed          Journal:  Subst Use Misuse        ISSN: 1082-6084            Impact factor:   2.164


  23 in total

1.  Smoking and musculoskeletal disorders: findings from a British national survey.

Authors:  K T Palmer; H Syddall; C Cooper; D Coggon
Journal:  Ann Rheum Dis       Date:  2003-01       Impact factor: 19.103

2.  Prevalence and patterns of opioid misuse and opioid use disorder among primary care patients who use tobacco.

Authors:  William S John; He Zhu; Paolo Mannelli; Geetha A Subramaniam; Robert P Schwartz; Jennifer McNeely; Li-Tzy Wu
Journal:  Drug Alcohol Depend       Date:  2018-11-26       Impact factor: 4.492

Review 3.  Are Pharmacotherapies Ineffective in Opioid-Dependent Smokers? Reflections on the Scientific Literature and Future Directions.

Authors:  Mollie E Miller; Stacey C Sigmon
Journal:  Nicotine Tob Res       Date:  2015-08       Impact factor: 4.244

4.  Smoking history, nicotine dependence and opioid use in patients with chronic non-malignant pain.

Authors:  K Plesner; H I Jensen; J Højsted
Journal:  Acta Anaesthesiol Scand       Date:  2016-05-10       Impact factor: 2.105

5.  Tobacco Smoking, Nicotine Dependence, and Patterns of Prescription Opioid Misuse: Results From a Nationally Representative Sample.

Authors:  Emily L Zale; Michelle L Dorfman; W Michael Hooten; David O Warner; Michael J Zvolensky; Joseph W Ditre
Journal:  Nicotine Tob Res       Date:  2014-10-25       Impact factor: 4.244

6.  Associations between opioid and nicotine dependence in nationally representative samples of United States adult daily smokers.

Authors:  Maria A Parker; Joanna M Streck; Stacey C Sigmon
Journal:  Drug Alcohol Depend       Date:  2018-03-15       Impact factor: 4.492

7.  Pain inhibition, nicotine, and gender.

Authors:  L D Jamner; S S Girdler; D Shapiro; M E Jarvik
Journal:  Exp Clin Psychopharmacol       Date:  1998-02       Impact factor: 3.157

8.  Gender differences in the pharmacology of nicotine addiction.

Authors:  N L Benowitz; D Hatsukami
Journal:  Addict Biol       Date:  1998-10       Impact factor: 4.280

9.  Patient characteristics associated with buprenorphine/naloxone treatment outcome for prescription opioid dependence: Results from a multisite study.

Authors:  Jessica A Dreifuss; Margaret L Griffin; Katherine Frost; Garrett M Fitzmaurice; Jennifer Sharpe Potter; David A Fiellin; Jeffrey Selzer; Mary Hatch-Maillette; Susan C Sonne; Roger D Weiss
Journal:  Drug Alcohol Depend       Date:  2013-01-18       Impact factor: 4.492

10.  Current Cigarette Smoking Among Adults - United States, 2016.

Authors:  Ahmed Jamal; Elyse Phillips; Andrea S Gentzke; David M Homa; Stephen D Babb; Brian A King; Linda J Neff
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-01-19       Impact factor: 17.586

View more
  1 in total

Review 1.  Factors mediating pain-related risk for opioid use disorder.

Authors:  Arbi Nazarian; S Stevens Negus; Thomas J Martin
Journal:  Neuropharmacology       Date:  2021-01-30       Impact factor: 5.250

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.